Glaxosmithkline Regulatory News (GSK)

1

Receive and adopt the 2022 Annual Report

2,838,286,554

99.05

27,282,840

0.95

2,865,569,394

11,463,434

2

Approve the Annual report on remuneration 

2,493,636,361

88.84

313,256,226

11.16

2,806,892,587

70,129,301

3

Election of Julie Brown

2,857,379,637

99.59

11,814,146

0.41

2,869,193,783

7,831,272

4

Election of Dr Vishal Sikka

2,860,647,976

99.69

8,837,033

0.31

2,869,485,009

7,534,298

5

Election of Elizabeth McKee Anderson

2,744,478,188

95.64

125,073,699

4.36

2,869,551,887

7,475,279

6

Re-election of Sir Jonathan Symonds

2,774,824,580

96.72

94,170,389

3.28

2,868,994,969

8,020,637

7

Re-election of Dame Emma Walmsley

2,862,165,104

99.74

7,358,771

0.26

2,869,523,875

7,508,911

8

Re-election of Charles Bancroft

2,786,237,098

97.24

79,167,334

2.76

2,865,404,432

11,602,033

9

Re-election of Dr Hal Barron

2,845,192,710

99.17

23,938,850

0.83

2,869,131,560

7,896,993

10

Re-election of Dr Anne Beal

2,788,179,755

97.17

81,326,824

2.83

2,869,506,579

7,517,274

11

Re-election of Dr Harry C Dietz

2,863,558,514

99.83

4,932,171

0.17

2,868,490,685

8,534,053

12

Re-election of Dr Jesse Goodman

2,863,346,622

99.79

6,079,498

0.21

2,869,426,120

7,596,197

13

Re-election of Urs Rohner

2,627,550,485

91.58

241,613,171

8.42

2,869,163,656

7,856,370

14

Re-appointment of the auditor

2,846,403,783

99.86

4,095,644

0.14

2,850,499,427

26,524,596

15

Remuneration of the auditor

2,865,552,679

99.83

4,889,379

0.17

2,870,442,058

6,575,928

16

Approve amendments to the Directors' Remuneration Policy

2,837,886,999

99.01

28,431,513

0.99

2,866,318,512

10,705,019

17

Authority for the company to make donations to political organisations and incur political expenditure

2,778,351,786

98.69

36,846,645

1.31

2,815,198,431

61,881,372

18

Authority to allot shares

2,749,592,663

95.85

118,984,091

4.15

2,868,576,754

8,438,938

19

Disapplication of pre-emption rights - general power(4)

2,774,457,577

96.79

91,974,467

3.21

2,866,432,044

10,561,299

20

Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment(4)

2,747,347,831

95.84

119,258,296

4.16

2,866,606,127

10,393,035

21

Authority for the company to purchase its own shares(4)

2,821,937,695

98.36

47,051,419

1.64

2,868,989,114

8,025,806

22

Exemption from statement of senior statutory auditor's name

2,856,668,700

99.67

9,373,459

0.33

2,866,042,159

10,967,927

23

Authority for reduced notice of a general meeting other than an AGM(4)

2,698,567,258

94.08

169,932,106

5.92

2,868,499,364

8,505,572

GSK's 23rd AGM

(Hybrid meeting)

(2023)

GSK's 22nd AGM

(Hybrid meeting)

(2022)

Issued share capital (excluding Treasury Shares)

4,094,980,743

5,083,974,547

Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)

70.26%

70.25%

Total shareholder population

63,362

89,764

Total number of proxies lodged

3,162

5,343

Number of shareholders in attendance

72 in person

49 participated virtually

93 in person

68 participated virtually

% of shareholders who lodged proxies

4.99%

5.95%